机构

• 海洋研究所 [60]
• 上海药物研究所 [24]
• 水生生物研究所 [18]
• 过程工程研究所 [17]
• 南海海洋研究所 [11]
• 西北高原生物研究所 [9]
• 更多

采集方式

• OAI收割 [218]
• iSwitch采集 [14]

内容类型

• 期刊论文 [208]
• 学位论文 [23]
• 会议论文 [1]

发表日期

• 2023 [7]
• 2022 [6]
• 2021 [8]
• 2020 [10]
• 2019 [16]
• 2018 [24]
• 更多

学科主题

• Immunolog... [35]
• Fisheries [20]
• Marine & ... [18]
• Veterinar... [16]
• Zoology [12]
• Fisheries;... [8]
• 更多

筛选

浏览/检索结果: 共232条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Deubiquitylating Enzymes in Cancer and Immunity 期刊论文  OAI收割 ADVANCED SCIENCE, 2023, 页码: 37 作者:  Ren, Jiang;  Yu, Peng;  Liu, Sijia;  Li, Ran;  Niu, Xin   |  收藏  |  浏览/下载：6/0  |  提交时间：2023/12/08 cancer  deubiquitylating enzymes (DUBs)  immunity  therapeutic approach   Metabolic profiling of Apostichopus japonicus body wall exposed to a typical type of PBDEs: potential health risks and impact on sea cucumber health 期刊论文  OAI收割 FRONTIERS IN MARINE SCIENCE, 2023, 卷号: 10, 页码: 15 作者:  Ding, Kui;  Zhuo, Pengji;  Ge, Meiling;  Liao, Xiaomei;  Mo, Jing   |  收藏  |  浏览/下载：7/0  |  提交时间：2023/11/30 sea cucumber  BDE-47  body wall  metabolite  metabolic pathway   Breaking Tumor Immunosuppressive Network by Regulating Multiple Nodes with Triadic Drug Delivery Nanoparticles 期刊论文  OAI收割 ACS NANO, 2023, 卷号: 17, 期号: 18, 页码: 17826-17844 作者:  Yan, Wenlu;  Li, Yu;  Zou, Yiting;  Zhu, Runqi;  Wu, Ting   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/12/08 triple-negative breast cancer  antitumor immunity  tumor-associated macrophages  myeloid-derived suppressorcells  immune network  nanoparticle   A Mannose Receptor from Litopenaeus vannamei Involved in Innate Immunity by Pathogen Recognition and Inflammation Regulation 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 卷号: 24, 期号: 13, 页码: 19 作者:  Guo, Na;  Liu, Yuan;  Hao, Qiang;  Sun, Mingzhe;  Li, Fuhua   |  收藏  |  浏览/下载：5/0  |  提交时间：2023/12/13 mannose receptor  Litopenaeus vannamei  pathogen recognition  inflammation  ROS   Could IL-25 be a potential therapeutic target for intestinal inflammatory diseases? 期刊论文  OAI收割 CYTOKINE & GROWTH FACTOR REVIEWS, 2023, 卷号: 69, 页码: 43-50 作者:  Chen, Jie;  Wang, Yingshu;  Shen, Lan;  Xiu, Yanfeng;  Wang, Bing   |  收藏  |  浏览/下载：15/0  |  提交时间：2023/04/10 IL-25  Type-2 immunity  Inflammatory bowel disease   Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance 期刊论文  OAI收割 EMBO MOLECULAR MEDICINE, 2023, 页码: 24 作者:  Wang, Li-Min;  Wang, Pingyuan;  Chen, Xiao-Min;  Yang, Hui;  Song, Shan-Shan   |  收藏  |  浏览/下载：21/0  |  提交时间：2023/04/10 homologous recombination repair  olaparib-resistant  PARP inhibitor  PARP7  type I interferons   Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer 期刊论文  OAI收割 ADVANCED MATERIALS, 2023, 页码: 15 作者:  Chen, Fangmin;  Li, Tianliang;  Zhang, Huijuan;  Saeed, Madiha;  Liu, Xiaoying   |  收藏  |  浏览/下载：20/0  |  提交时间：2023/04/10 acid-ionizable nanoadjuvants  cancer vaccines  iron oxide nanoparticles  personalized immunotherapy  STING cascade activation   A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 卷号: 222, 页码: 661-670 作者:  He, Yunxia;  Yu, Weili;  Shen, Lijuan   |  收藏  |  浏览/下载：27/0  |  提交时间：2023/02/24 SARS-CoV-2  RBD  Adjuvant   Structure-Activity relationship study of benzothiophene oxobutanoic acid analogues leading to novel stimulator of interferon gene (STING) agonists 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 241, 页码: 16 作者:  Shen, Ancheng;  Li, Xiyuan;  Zhang, Yan;  Ma, Jing;  Xiao, Ruoxuan   |  收藏  |  浏览/下载：21/0  |  提交时间：2023/04/10 Innate immunity  STING Agonists  Structural modification  Immuno-oncology   Whole-transcriptome sequencing data reveals a disparate cognitive and immune signature in COVID-19 patients with and without dementia 期刊论文  OAI收割 JOURNAL OF MEDICAL VIROLOGY, 2022, 页码: 10 作者:  Yang, Jue;  Song, Hui;  Hao, Xiaojiang   |  收藏  |  浏览/下载：32/0  |  提交时间：2022/12/13 Alzheimer's disease  COVID-19  dementia  immune response  SARS-CoV-2